RumMAGE-D the members: Structure and function of a new adaptor family of MAGE-D proteins

Journal of Receptors and Signal Transduction

Volumn 25, Issue 3, 2005, Pages 181-198

  Sasaki, Aya ^a   Hinck, Lindsay ^b   Watanabe, Ken ^c  

^a SAPPORO MEDICAL UNIVERSITY HOSPITAL   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

Apoptosis; Dlx Msx; MAGE D; Necdin; NGFR (p75NTR); UNC5H

Indexed keywords

ADAPTOR PROTEIN; CELL SURFACE PROTEIN; MELANOMA ANTIGEN 1; MELANOMA ANTIGEN D; NECDIN; NERVE GROWTH FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; GENE; GENE SILENCING; MAGE GENE; MAJOR HISTOCOMPATIBILITY COMPLEX; MULTIGENE FAMILY; NONHUMAN; PRADER WILLI SYNDROME; PROTEIN DEGRADATION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; TRANSCRIPTION REGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIGENS, NEOPLASM; APOPTOSIS; CELL CYCLE; CELL LINE; CELL LINE, TUMOR; CELL MEMBRANE; HUMANS; MODELS, BIOLOGICAL; MULTIGENE FAMILY; NEOPLASM PROTEINS; NERVE TISSUE PROTEINS; NEURODEGENERATIVE DISEASES; NUCLEAR PROTEINS; PRADER-WILLI SYNDROME; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 26444451086     PISSN: 10799893     EISSN: 15324281     Source Type: Journal    
DOI: 10.1080/10799890500210511     Document Type: Article

References (66)

1. van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, Van den Eynde B, Knuth A, Boon T. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991, 254, 1643-1647.
2. Chomez P, De Backer O, Bertrand M, De Plaen E, Boon T, Lucas S. An overview of the MAGE gene family with the identification of all human members of the family. Cancer Res 2001, 61, 5544-5551.
3. Barker PA, Salehi A. The MAGE proteins: Emerging roles in cell cycle progression, apoptosis, and neurogenetic disease. J Neurosci Res 2002, 67, 705-712.
4. De Smet C, Lurquin C, Lethe B, Martelange V, Boon T. DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter. Mol Cell Biol 1999, 19, 7327-7335.
5. Boon T, Cerottini JC, Van den Eyende B, Van den Bruggen P, Van Pel A. Tumor antigens recognized by T lymphocytes. Annu Rev Immunol 1994, 12, 337-365.
6. Pold M, Zhou J, Chen GL, Hall JM, Vescio RA, Berenson JR. Identification of a new, unorthodox member of the MAGE gene family. Genomics 1999, 59, 161-167.
7. Salehi AH, Roux PP, Kubu CJ, Zeindler C, Bhakar A, Tannis LL, Verdi JM, Barker PA. NRAGE, a novel MAGE protein, interacts with the p75 neurotrophin receptor and facilitates nerve growth factor-dependent apoptosis. Neuron 2000, 27, 279-288.
8. Masuda Y, Sasaki A, Shibuya H, Ueno N, Ikeda K, Watanabe K. Dlxin-1, a novel protein that binds Dlx5 and regulates its transcriptional function. J Biol Chem 2001, 276, 5331-5338.
9. Pold A, Ma HJ, Sjak-Shieb NN, Vescio RA, Berensonb JR, Pold M. Identification of a new, unorthodox member of the MAGE gene family. Dev Comp Immunol 2000, 24, 719-731.
10. Bischof J, Ekker M, Wevrick R. A MAGE/NDN-like gene in zebrafish. Dev Dyn 2003, 228, 475-479.
11. Bertrand M, Huijbers I, Chomez P, Backer O. Comparative expression analysis of the MAGED genes during embryogenesis and brain development. Dev Dyn 2004, 230, 325-334.
12. Saburi S, Nadano D, Akama TO, Hirama K, Yamanouchi K, Naito K, Tojo H, Tachi C, Fukuda MN. The trophinin gene encodes a novel group of MAGE proteins, magphinins, and regulates cell proliferation during gametogenesis in the mouse. J Biol Chem 2001, 276, 49378-49389.
13. Sasaki M, Nakahira K, Kawano Y, Katakura H, Yoshimine T, Shimizu K, Kim SU, Ikenaka K. MAGE-E1, a new member of the melanoma-associated antigen gene family and its expression in human glioma. Cancer Res 2001, 61, 4809-4814.
14. Fukuda MN, Sato T, Nakayama J, Klier G, Mikami M, Aoki D, Nozawa S. Trophinin and tastin, a novel cell adhesion molecule complex with potential involvement in embryo implantation. Genes Dev 1995, 9, 1199-1210.
15. Albrecht DE, Froehner SC. DAMAGE, a novel alpha-dystrobrevin-associated MAGE protein in dystrophin complexes. J Biol Chem 2004, 279, 7014-703.
16. Stone B, Schummer M, Paley PJ, Crawford M, Ford M, Urban N, Nelson BH. MAGE-F1, a novel ubiquitously expressed member of the MAGE superfamily. Gene 2001, 267, 173-182.
17. Andrade MA, Perez-Iratxeta C, Ponting CP. Protein repeats: Structures, functions, and evolution. J Struct Biol 2001, 134, 117-131.
18. Brookfield JF. Genome sequencing: The ripping yarn of the frozen genome. Curr Biol 2003, 13, R552-R553.
19. Barker P. p75NTR is positively promiscuous: Novel partners and new insights. Neuron 2004, 42, 529-533.
20. Bibel M, Barde YA. Neurotrophins: Key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev 2000, 14, 2919-2937.
21. Lee R, Kermani P, Teng K, Hempstead B. Regulation of cell survival by secreted proneurotrophins. Science 2001, 294, 1945-1948.
22. Beattie MS, Harrington AW, Lee R, Kim JY, Boyce SL, Longo FM, Bresnahan JC, Hempstead BL, Yoon SO. ProNGF induces p75-mediated death of oligodendrocytes following spinal cord injury. Neuron 2002, 36, 375-386.
23. Lu B. Pro-region of neurotrophins: Role in synaptic modulation. Neuron 2003, 9, 735-738.
24. Salehi AH, Xanthoudakis S, Barker PA. NRAGE, a p75 neurotrophin receptor-interacting protein, induces caspase activation and cell death through a JNK-dependent mitochondrial pathway. J Biol Chem 2002, 277, 48043-48050.
25. Bronfman FC, Tcherpakov M, Jovin TM, Fainzilber M. Ligand-induced internalization of the p75 neurotrophin receptor: A slow route to the signaling endosome. J Neurosci 2003, 23, 3209-3220.
26. Nielsen MS, Madsen P, Christensen EI, Nykjaer A, Gliemann J, Kasper D, Pohlmann R, Petersen CM. The sortilin cytoplasmic tail conveys Golgi-endosome transport and binds the VHS domain of the GGA2 sorting protein. EMBO J 2001, 20, 2180-2190.
27. Nykjaer A, Lee R, Teng K, Jansen P, Madsen P, Nielsen MS, Jacobsen C, Kliemannel M, Schwarz E, Willnow TE, Hempstead BL, Peterson CM. Sortilin is essential for proNGF-induced neuronal cell death. Nature 2004, 427, 843-848
28. Wang KC, Kim JA, Sivasankaran R, Segal R, He Z. P75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp. Nature 2002, 420, 74-78.
29. Mi S, Lee X, Shao Z, Thill G, Ji B, Relton J, Levesque M, Allaire N, Perrin S, Sands B, Crowell T, Cate RL, McCoy JM, Pepinsky RB. LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex. Nat Neurosci 2004, 7, 221-228.
30. Yamashita T, Tohyama M. The p75 receptor acts as a displacement factor that releases Rho from Rho-GDI. Nat Neurosci 2003, 6, 461-467
31. Kendall S, Goldhawk D, Kubu C, Barker P, Verdi J. Expression analysis of a novel p75(NTR) signaling protein, which regulates cell cycle progression and apoptosis. Mech Dev 2002, 117, 187-200.
32. Williams ME, Strickland P, Watanabe K, Hinck L. UNC5H1 induces apoptosis via its juxtamembrane region through an interaction with NRAGE. J Biol Chem 2003, 278, 17483-17490.
33. Hong K, Hinck L, Nishiyama M, Poo M, Tessier-Lavigne M, Stein E. A ligand-gated association between cytoplasmic domains of UNC5 and DCC family receptors converts netrin-induced growth cone attraction to repulsion. Cell 1999, 97, 927-941.
34. Llambi F, Causeret F, Bloch-Gallego E, Mehlen P. Netrin-1 acts as a survival factor via its receptors UNC5H and DCC. EMBO J 2001, 20, 2715-2722.
35. Tanikawa C, Matsuda K, Fukuda S, Nakamura Y, Arakawa H. p53RDL1 regulates p53-dependent apoptosis. Nat Cell Biol 2003, 5, 216-223.
36. Kanning KC, Hudson M, Amieux PS, Wiley JC, Bothwell M, Schecterson LC. Proteolytic processing of the p75 neurotrophin receptor and two homologs generates C-terminal fragments with signaling capability. J Neurosci 2003, 23, 5425-5436.
37. Matsuda T, Suzuki H, Oishi I, Kani S, Kuroda Y, Komori T, Sasaki A, Watanabe K, Minami Y. The receptor tyrosine kinase Ror2 associates with the melanoma-associated antigen (MAGE) family protein Dlxin-1 and regulates its intracellular distribution. J Biol Chem 2003, 278, 29057-290.
38. Ryoo H, Hoffmann H, Beumer T, et al. Stage-specific expression of Dlx-5 during osteoblast differentiation: Involvement in regulation of osteocalcin gene expression. Mol Endocrinol 1997, 11, 1681-1694.
39. Lee M, Kim YJ, Kim HJ, Park HD, Kang AR, Kyung HM, Sung JH, Wozney JM, Kim HJ, Ryoo HM. BMP-2-induced Runx2 expression is mediated by Dlx5, and TGF-beta 1 opposes the BMP-2-induced osteoblast differentiation by suppression of Dlx5 expression. J Biol Chem 2003, 278, 34387-34394.
40. Acampora D, Merlo GE, Paleari L, Zerega B, Postiglione MP, Mantero S, Bober E, Barbieri O, Simeone A, Levi G. Craniofacial, vestibular and bone defects in mice lacking the Distal-less-related gene Dlx5. Development 1999, 126, 3795-3809.
41. Depew MJ, Liu JK, Long JE, Presley E, Meneses JJ, Pedersen EA, Rubenstein JL. Dlx5 regulates regional development of the branchial arches and sensory capsules. Development 1999, 126, 3831-3846.
42. Zou H, Niswander L. Requirement for BMP signaling in interdigital apoptosis and scale formation. Science 1996, 272, 738-741.
43. Graham A, Francis-West P, Brickell P, Lumsden A. The signalling molecule BMP4 mediates apoptosis in the rhombencephalic neural crest. Nature 1994, 372, 684-686.
44. Yoda A, Oishi I, Minami Y. Expression and function of the Ror-family receptor tyrosine kinases during development: Lessons from genetic analyses of nematodes, mice, and humans. J Recept Signal Transduct Res 2003, 23, 1-15.
45. Patton M, Afzal A. Robinow syndrome. J Med Genet 2002, 39, 305-310.
46. Hikasa H, Shibata M, Hiratani I, Taira M. The Xenopus receptor tyrosine kinase Xror2 modulates morphogenetic movements of the axial mesoderm and neuroectoderm via Wnt signaling. Development 2002, 29, 5227-5239.
47. Brunelli S, Tagliafico E, De Angelis FG, Tonlorenzi E, Baesso S, Ferrari S, Niinobe M, Yoshikawa K, Schwartz RJ, Bozzoni I, Ferrari S, Cossu G. Msx2 and necdin combined activities are required for smooth muscle differentiation in mesoangioblast stem cells. Circ Res 2004, 94, 1571-1578.
48. Kuwajima T, Taniura H, Nishimura I, Yoshikawa K. Necdin interacts with the Msx2 homeodomain protein via MAGE-D1 to promote myogenic differentiation of C2C12 cells. J Biol Chem 2004, 279, 40484-40493.
49. Sasaki A, Masuda Y, Iwai K, Ikeda K, Watanabe K. A RING finger protein Praja1 regulates Dlx5-dependent transcription through its ubiquitin ligase activity for the Dlx/Msx-interacting MAGE/Necdin family protein, Dlxin-1. J Biol Chem 2002, 277, 22541-22546.
50. Jordan BW, Dinev D, LeMellay V, Troppmair J, Goetz E, Wixler L, Sendtner M, Ludwig S, Rapp UR. Neurotrophin receptor-interacting mage homologue is an inducible inhibitor of apoptosis protein-interacting protein that augments cell death. J Biol Chem 2001, 276, 39985-39989.
51. Liston P, Fong WG, Korneluk G. The inhibitors of apoptosis: There is more to life than Bcl2. Oncogene 2003, 22, 8568-8580.
52. Wen CJ, Xue B, Qin WX, Yu M, Zhang MY, Zhao DH, Gao X, Gu JE, Li CJ. HNRAGE, a human neurotrophin receptor interacting MAGE homologue, regulates p53 transcriptional activity and inhibits cell proliferation. FEBS Lett 2004, 564, 171-176.
53. Bruno T, De Angelis R, De Nicola F, Barbato C, Di Padova M, Corbi N, Libri V, Benassi B, Mattei E, Chersi A, Soddu S, Floridi A, Passananti C, Fanciulli M. Che-1 affects cell growth by interfering with the recruitment of HDAC1 by Rb. Cancer Cell 2002, 2, 387-399.
54. Taniura H, Taniguchi N, Hara M, Yoshikawa K. Necdin, a postmitotic neuron-specific growth suppressor, interacts with viral transforming proteins and cellular transcription factor E2F1. J Biol Chem 1998, 273, 720-728.
55. Taniura H, Matsumoto K, Yoshikawa K. Physical and functional interactions of neuronal growth suppressor necdin with p53. J Biol Chem 1999, 274, 16242-16248.
56. Taniguchi N, Taniura H, Niinobe M, Takayama C, Tominaga-Yoshino K, Ogura A, Yoshikawa K. The postmitotic growth suppressor necdin interacts with a calcium-binding protein (NEFA) in neuronal cytoplasm. J Biol Chem 2000, 275, 31674-31681.
57. Kuwako K, Taniura H, Yoshikawa K. Necdin-related MAGE proteins differentially interact with the E2F1 transcription factor and the p75 neurotrophin receptor. J Biol Chem 2004, 279, 1703-1712.
58. Uetsuki T, Takagi K, Sugiura H, Yoshikawa K. Structure and expression of the mouse necdin gene. Identification of a postmitotic neuron-restrictive core promoter. J Biol Chem 1996, 271, 918-924.
59. Yang T, Adamson T, Resnick J, Leff S, Wevrick R, Francke U, Jenkins NA, Copeland NG, Brannan CI. A mouse model for Prader-Willi syndrome imprinting-centre mutations. Nat Genet 1998, 19, 25-31.
60. Tsai T, Armstrong D, Beaudet A. Necdin-deficient mice do not show lethality or the obesity and infertility of Prader-Willi syndrome. Nat Genet 1999, 22, 15-6.
61. Gerard M, Hernandez L, Wevrick R, Stewart CL. Disruption of the mouse necdin gene results in early post-natal lethality. Nat Genet 1999, 23, 199-202.
62. Ren J, Lee S, Pagliardini S, Gerard M, Stewart CL, Greer JJ, Wevrick R. Absence of Ndn, encoding the Prader-Willi syndrome-deleted gene necdin, results in congenital deficiency of central respiratory drive in neonatal mice. J Neurosci 2003, 23, 1569-1573.
63. Muscatelli F, Abrous DN, Massacrier A, Boccaccio I, Le Moal M, Cau P, Cremer H. Disruption of the mouse necdin gene results in hypothalamic and behavioral alterations reminiscent of the human Prader-Willi syndrome. Hum Mol Genet 2000, 9, 3101-3110.
64. Lee S, Kozlov S, Hernandez L, Chamberlain SJ, Brannnan CI, Stewart CL, Wevrick R. Expression and imprinting of MAGEL2 suggest a role in Prader-Willi syndrome and the homologous murine imprinting phenotype. Hum Mol Genet 2000, 9, 1813-1819.
65. Lee J. Molecular links between X-inactivation and autosomal imprinting: X-inactivation as a driving force for the evolution of imprinting? Curr Biol 2003, 13, R242-54.
66. Tcherpakov M, Bronfman FC, Conticello SG, Vaskovsky A, Levy Z, Niinobe M, Yoshikawa K, Arenas E, Fainzilber M. The p75 neurotrophin receptor interacts with multiple MAGE proteins. J Biol Chem 2002, 277, 49101-49104.